B

Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML

Watchlist Manager
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Watchlist
Price: 5.8 PLN 1.67%
Market Cap: 378.5m PLN

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
B
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Cash from Operating Activities
zł2.9m
CAGR 3-Years
-29%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
M
Mabion SA
WSE:MAB
Cash from Operating Activities
-zł40.5m
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
R
Read Gene SA
WSE:RDG
Cash from Operating Activities
zł2m
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genomed SA
WSE:GEN
Cash from Operating Activities
zł1.6m
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
N/A
B
Bioton SA
WSE:BIO
Cash from Operating Activities
zł32.5m
CAGR 3-Years
-19%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
S
Synthaverse SA
WSE:SVE
Cash from Operating Activities
zł1.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Glance View

Market Cap
407.5m PLN
Industry
Biotechnology

Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. The company is headquartered in Lublin, Woj. Lubelskie and currently employs 223 full-time employees. The company went IPO on 2011-07-29.

BML Intrinsic Value
Not Available
B

See Also

What is Biomed Lublin Wytwornia Surowic i Szczepionek SA's Cash from Operating Activities?
Cash from Operating Activities
2.9m PLN

Based on the financial report for Dec 31, 2022, Biomed Lublin Wytwornia Surowic i Szczepionek SA's Cash from Operating Activities amounts to 2.9m PLN.

What is Biomed Lublin Wytwornia Surowic i Szczepionek SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-8%

The average annual Cash from Operating Activities growth rates for Biomed Lublin Wytwornia Surowic i Szczepionek SA have been -29% over the past three years , -8% over the past five years .

Back to Top